AI imaging for skin cancer margin detection
Part of Cancer clinical trials.
This study tests an AI-enhanced imaging technique to help doctors see the edges of a common type of skin cancer called basal cell carcinoma before surgery. It may help ensure the cancer is removed completely the first time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have at least one basal cell carcinoma that is the superficial or nodular type (the most common types).
- You are willing to have photos taken of the treatment area.
- You are willing to sign a consent form and have a biopsy if needed.
- You are not pregnant and do not have a herpes infection in the treatment area.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new imaging methods to look at basal cell carcinoma, a common type of skin cancer, when you're already getting it treated. The goal is to see how well these imaging tools work in a real clinic setting, which may help improve how skin cancer is assessed in the future.
This study uses artificial intelligence to analyze magnified skin images of basal cell carcinoma to predict the cancer's subtype and risk classification. It aims to improve diagnosis and treatment planning without additional procedures.
This study is testing whether an artificial intelligence (AI) system can accurately diagnose basal cell carcinoma, a common type of skin cancer, from microscope slide images. If you have had a biopsy slide of a skin lesion that was already diagnosed as basal cell carcinoma, your sample might be used to help train or test the AI.
This trial tests a special microscope that uses artificial intelligence (AI) to help surgeons see exactly where skin cancer (basal cell carcinoma) ends during surgery. This could help remove all cancer cells in one go, making repeat surgeries less likely.
This study is testing a new imaging technology that helps surgeons see if all the cancer cells have been removed during Mohs surgery for basal cell carcinoma. It may help improve accuracy and reduce the need for additional surgeries.
This study tests whether an artificial intelligence (AI) system can better find the small markers placed during breast biopsies using ultrasound images. It may help improve how these markers are detected in the future.
Hear when a new Basal Cell Carcinoma of Skin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.